iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Down 34.0% in April

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a large decline in short interest in the month of April. As of April 30th, there was short interest totaling 1,522 shares, a decline of 34.0% from the April 15th total of 2,307 shares. Based on an average trading volume of 1,233 shares, the short-interest ratio is presently 1.2 days. Approximately 1.0% of the shares of the company are short sold.

iShares Neuroscience and Healthcare ETF Price Performance

Shares of IBRN traded down $0.26 during midday trading on Tuesday, hitting $33.68. 896 shares of the company traded hands, compared to its average volume of 1,804. The stock has a 50-day moving average of $33.50 and a 200-day moving average of $32.24. iShares Neuroscience and Healthcare ETF has a one year low of $21.78 and a one year high of $37.00. The firm has a market cap of $5.05 million, a P/E ratio of 15.61 and a beta of 0.77.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.